![]() |
|
|
Vol. 301, Issue 3, 797-802, June 2002
Department of Pharmacology and Toxicology, Kyorin University School
of Medicine, Tokyo, Japan (M.T., S.N., Yu.K., T.S., S.H.C., H.E.);
Department of Clinical Preventive Medicine, Nagoya University School of
Medicine, Nagoya, Japan (A.E., T.N.); Department of Veterinary
Medicine, Faculty of Agriculture, Tokyo University of Agriculture and
Technology, Tokyo, Japan (M.S.); and Department of Clinical Pharmacy,
Showa University School of Pharmaceutical Sciences, Tokyo, Japan.
(Ya.K., T.Y.)
The organic anion transport system is involved in the tubular excretion
and reabsorption of various drugs and substances. The purpose of this
study was to characterize the effects of various organic anion
transport inhibitors on renal organic anion transport using proximal
tubule cells stably expressing human organic anion transporter 2 (hOAT2) and hOAT4. Immunohistochemical analysis revealed that hOAT2 is
localized to the basolateral side of the proximal tubule in the kidney.
hOAT2 mediated a time- and concentration-dependent increase in
prostaglandin F2
(PGF2
) uptake. The
organic anion transport inhibitors used for this study were probenecid, 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), betamipron, and
cilastatin. Probenecid, but not KW-3902, betamipron, and cilastatin, significantly inhibited hOAT2-mediated PGF2
uptake. In
contrast, probenecid, KW-3902, and betamipron, but not cilastatin,
inhibited hOAT4-mediated estrone sulfate (ES) uptake. Kinetic analyses
revealed that these inhibitions were competitive. The
Ki value of probenecid for hOAT2 was 766 µM, whereas those of probenecid, KW-3902, and betamipron for hOAT4
were 54.9, 20.7, and 502 µM, respectively. These results suggest that
probenecid, KW-3902, and betamipron could inhibit hOAT4-mediated ES
uptake in vitro, whereas probenecid alone could inhibit the
hOAT2-mediated PGF2
uptake. Comparing the
Ki values with the therapeutically relevant
concentrations of unbound inhibitors in the plasma, probenecid alone
was predicted to inhibit hOAT4-mediated organic anion transport in vivo.
This article has been cited by other articles:
![]() |
P. Duan and G. You Novobiocin Is a Potent Inhibitor for Human Organic Anion Transporters Drug Metab. Dispos., June 1, 2009; 37(6): 1203 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Kwon, H. S. Cheong, J.-Y. Rhee, Y. M. Wi, S. Y. Ryu, S. T. Heo, C. S. Moon, H. K. Ki, K. H. Kim, C. W. Jung, et al. Panipenem Versus Cefepime as Empirical Monotherapy in Adult Cancer Patients with Febrile Neutropenia: A Prospective Randomized Trial Jpn. J. Clin. Oncol., January 17, 2008; (2008) hym151v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hong, F. Zhou, K. Lee, and G. You The Putative Transmembrane Segment 7 of Human Organic Anion Transporter hOAT1 Dictates Transporter Substrate Binding and Stability J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1209 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ljubojevic, D. Balen, D. Breljak, M. Kusan, N. Anzai, A. Bahn, G. Burckhardt, and I. Sabolic Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones Am J Physiol Renal Physiol, January 1, 2007; 292(1): F361 - F372. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Schnabolk, G. L. Youngblood, and D. H. Sweet Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20) Am J Physiol Renal Physiol, August 1, 2006; 291(2): F314 - F321. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Eraly, V. Vallon, D. A. Vaughn, J. A. Gangoiti, K. Richter, M. Nagle, J. C. Monte, T. Rieg, D. M. Truong, J. M. Long, et al. Decreased Renal Organic Anion Secretion and Plasma Accumulation of Endogenous Organic Anions in OAT1 Knock-out Mice J. Biol. Chem., February 24, 2006; 281(8): 5072 - 5083. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Deguchi, M. Takemoto, N. Uehara, W. E. Lindup, A. Suenaga, and M. Otagiri Renal Clearance of Endogenous Hippurate Correlates with Expression Levels of Renal Organic Anion Transporters in Uremic Rats J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 932 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hashimoto, S. Narikawa, X.-L. Huang, T. Minematsu, T. Usui, H. Kamimura, and H. Endou CHARACTERIZATION OF THE RENAL TUBULAR TRANSPORT OF ZONAMPANEL, A NOVEL {alpha}-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID RECEPTOR ANTAGONIST, BY HUMAN ORGANIC ANION TRANSPORTERS Drug Metab. Dispos., October 1, 2004; 32(10): 1096 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Youngblood and D. H. Sweet Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney Am J Physiol Renal Physiol, August 1, 2004; 287(2): F236 - F244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hasannejad, M. Takeda, K. Taki, H. J. Shin, E. Babu, P. Jutabha, S. Khamdang, M. Aleboyeh, M. L. Onozato, A. Tojo, et al. Interactions of Human Organic Anion Transporters with Diuretics J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1021 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lungkaphin, V. Chatsudthipong, K. K. Evans, C. E. Groves, S. H. Wright, and W. H. Dantzler Interaction of the metal chelator DMPS with OAT1 and OAT3 in intact isolated rabbit renal proximal tubules Am J Physiol Renal Physiol, January 1, 2004; 286(1): F68 - F76. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Reid, P. Wielinga, N. Zelcer, I. van der Heijden, A. Kuil, M. de Haas, J. Wijnholds, and P. Borst The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs PNAS, August 5, 2003; 100(16): 9244 - 9249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hasegawa, H. Kusuhara, H. Endou, and Y. Sugiyama Contribution of Organic Anion Transporters to the Renal Uptake of Anionic Compounds and Nucleoside Derivatives in Rat J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1087 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Sweet, L. M. S. Chan, R. Walden, X.-P. Yang, D. S. Miller, and J. B. Pritchard Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient Am J Physiol Renal Physiol, April 1, 2003; 284(4): F763 - F769. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khamdang, M. Takeda, R. Noshiro, S. Narikawa, A. Enomoto, N. Anzai, P. Piyachaturawat, and H. Endou Interactions of Human Organic Anion Transporters and Human Organic Cation Transporters with Nonsteroidal Anti-Inflammatory Drugs J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 534 - 539. [Abstract] [Full Text] [PDF] |
||||